Pfizer Ventures (US) LLC 4
4 · IMARA Inc. · Filed Mar 16, 2020
Insider Transaction Report
Form 4
IMARA Inc.IMRA
PFIZER INC
10% Owner
Transactions
- Purchase
Common Stock
2020-03-16$16.00/sh+312,500$5,000,000→ 1,481,719 total(indirect: By LLC) - Conversion
Series A Preferred Stock
2020-03-16−5,470,492→ 0 total(indirect: By LLC)→ Common Stock (868,467 underlying) - Conversion
Series B Preferred Stock
2020-03-16−1,894,444→ 0 total(indirect: By LLC)→ Common Stock (300,752 underlying) - Conversion
Common Stock
2020-03-16+300,752→ 1,169,219 total(indirect: By LLC) - Conversion
Series Seed Preferred Stock
2020-03-16−478,749→ 0 total→ Common Stock (76,003 underlying) - Conversion
Common Stock
2020-03-16+76,003→ 76,003 total - Conversion
Common Stock
2020-03-16+868,467→ 868,467 total(indirect: By LLC)
Footnotes (5)
- [F1]On March 16, 2020, each share of Series Seed Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series Seed Preferred Stock had no expiration date.
- [F2]On March 16, 2020, each share of Series A Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.
- [F3]On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
- [F4]Each reporting person disclaims ownership of securities held by each other reporting person, except to the extent of its respective pecuniary interest therein.
- [F5]Pfizer Ventures (US) LLC purchased 312,500 additional shares of common stock in the Issuer's initial public offering at the initial public offering price of $16.00 per share.